Author

Emily Valentino

Institution: Memorial Sloan Kettering Cancer Center

Observed institution: Memorial Sloan Kettering Cancer Center

ORCID: 0000-0001-5068-5755

Observed ORCID: 0000-0001-5068-5755

OpenAlex ID: A5084948691

Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology

2016 · Nitya Raj, Emily Valentino, et al. · Pancreas · 111

Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar Carcinoma

2020 · Ghassan K. Abou-Alfa, Robert Mayer, et al. · The Oncologist · 47

A phase 1 study of ADI-PEG 20 and modified FOLFOX6 in patients with advanced hepatocellular carcinoma and other gastrointestinal malignancies

2018 · James J. Harding, Richard K. Do, et al. · Cancer Chemotherapy and Pharmacology · 45

Binimetinib plus Gemcitabine and Cisplatin Phase I/II Trial in Patients with Advanced Biliary Cancers

2018 · Maeve A. Lowery, Mikaela Bradley, et al. · Clinical Cancer Research · 35

A multicenter pilot study of nivolumab (NIVO) with drug eluting bead transarterial chemoembolization (deb-TACE) in patients (pts) with liver limited hepatocellular carcinoma (HCC).

2018 · James J. Harding, Joseph Patrick Erinjeri, et al. · Journal of Clinical Oncology · 14

Next-generation sequencing (NGS) in advanced well differentiated pancreatic neuroendocrine tumors (WD pNETs): A study using MSK-IMPACT.

2016 · Nitya Prabhakar Raj, Tara Soumerai, et al. · Journal of Clinical Oncology · 8

Next-generation sequencing (NGS) in advanced well differentiated pancreatic neuroendocrine tumors (WD pNETs): A study using MSK-IMPACT.

2016 · Nitya Prabhakar Raj, Tara Soumerai, et al. · Journal of Clinical Oncology · 3

Treatment response and outcomes of grade 3 (G3) pancreatic neuroendocrine carcinomas (HGNEC) based on pathologic differentiation.

2015 · Nitya Prabhakar Raj, Emily Valentino, et al. · Journal of Clinical Oncology · 3

Low objective response and high toxicity to single-agent mitotane in patients with metastatic adrenocortical carcinoma (ACC): A 25 year experience at MSKCC.

2015 · Betty Y Lung, Emily Valentino, et al. · Journal of Clinical Oncology · 1

ADI-PEG 20 and FOLFOX6: A phase 1 study in pts (pts) with advanced hepatocellular carcinoma (HCC).

2018 · James J. Harding, Richard K. G. Do, et al. · Journal of Clinical Oncology

Molecular landscape of fibrolamellar carcinoma (FLC): Beyond the DNAJB1-PRKACA chimera.

2017 · Imane Hassan El Dika, Marinela Capanu, et al. · Journal of Clinical Oncology

Works count: 11

Citation count: 267

H-index: 6

I10-index: 5